CausalSentinel

Protein Dossier — WISP1 (CCN family member 4)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Rheumatoid arthritis -0.142 0.0374 1.46e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypothyroidism or myxoedema -0.0754 0.0255 0.00304 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hyperthyroidism or thyrotoxicosis -0.172 0.0737 0.0194 Wald ratio 1 cis NA
ER-negative Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.0655 0.0288 0.0227 Wald ratio 1 cis NA
Forced vital capacity (FVC) -0.00898 0.00435 0.039 Wald ratio 1 cis NA
Hearing difficulty or problems: Yes 0.0179 0.009 0.0463 Wald ratio 1 cis NA
Non-cancer illness code self-reported: osteoporosis -0.0915 0.0468 0.0505 Wald ratio 1 cis NA
Non-cancer illness code self-reported: pernicious anaemia 0.161 0.0839 0.0542 Wald ratio 1 cis NA
Serum cystatin C (eGFRcys) -0.00821 0.0043 0.0563 Wald ratio 1 cis NA
Forced expiratory volume in 1-second (FEV1) -0.00838 0.00459 0.0679 Wald ratio 1 cis NA
Urate 0.0235 0.0131 0.0733 Wald ratio 1 cis NA
Diagnoses - main ICD10: N92 Excessive frequent and irregular menstruation 0.0619 0.0348 0.0752 Wald ratio 1 cis NA
…and 97 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3057_55_1 WISP-1 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

No GWAS Catalog associations mapped to this gene.

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 488 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
hypothyroidism 0.769 common-variant locus MR: beta=-0.0754, p=0.00304 (cis)
Graves disease 0.738 common-variant locus no MR -> candidate analysis
rheumatoid arthritis 0.656 common-variant locus MR: beta=-0.142, p=1.46e-04 (cis)
myxedema 0.656 common-variant locus no MR -> candidate analysis
thyrotoxicosis 0.591 common-variant locus MR: beta=-0.172, p=0.0194 (cis)
autoimmune disease 0.525 common-variant locus no MR -> candidate analysis
hyperthyroidism 0.525 common-variant locus MR: beta=-0.172, p=0.0194 (cis)
respiratory system disorder 0.509 common-variant locus no MR -> candidate analysis
hypotensive disorder 0.482 common-variant locus no MR -> candidate analysis
ovarian neoplasm 0.293 common-variant locus no MR -> candidate analysis
Back pain 0.23 common-variant locus no MR -> candidate analysis

Of the 11 rows above, 7 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint not available
GWAS Catalog no mapped SNPs
ClinVar no records
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance